NeuroPath captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in marker-less motion capturing, Quality of Life surveys, wearables, voice detection, medication schedule and life-style data.
Graphic user interfaces display reports and alerts on tailored dashboards for the inter-disciplinary stakeholders involved in the care path of people with Parkinson’s to allow early interventions.
Using AI, data is analyzed and transformed into objective parameters of disease progression to create insights into care path adherence, treatment results, drug efficacy and personalized care that can be shared with all stakeholders.

NeuroPath milestones

2021

Invited to participate in Veterans Health Administration Greenhouse Initiative Innovation Ecosystem

Appointed Kevin Donnelly to the Board of Directors

Appointed Ben Walshaw as Chief Technology Officer

CE Class I certification

2020

Appointed Koen Van den Brande as the Chief Solutions Officer and a PwP himself

Awarded 2nd Place in the Alumnae New Venture Challenge (ANVC) through the Polsky Centre of Innovation and Entrepreneurship at the University of Chicago

The BioWin Cluster awarded NeuroPath to lead the Neuro-Insight 36 month consortium project along with 2 technological and 2 clinical partners

The Walloon Export Agency, AWEx awarded NeuroPath to set up a legal entity in Chicago

Horizon 2020 funded the AICCELERATE smart hospital proposal led by HUS in Helsinki .   As one of the 15 partners from 8 countries, NeuroPath will lead the digital care path of Parkinson’s patients

Granted the freedom to incorporate Cloud UPDRS into our Navigator platform, to analyze tremor, gait and tapping performance using standard UPDRS methods. 

Pilot projects with patients through VPL and Parkinson’s Concierge

2019

Continuation of our trials in 3 locations including wearables and medication diary

Began our first trials with voice recordings

Expansion of our network of partners

MVP patient and caregiver ‘navigator’ application developed

Patent on marker-less motion capturing approved

Filed for 2 patents on change detection and voice 

Selected for the InvestHorizon Accelerator program

Signed a Collaborative Research Agreement with Texas A&M

Formed a collaboration with Northwestern Medical

Incorporated 
NeuroPath US, Inc. 

Installed 
Advisory Board 

Completed second round seed investors 

2018

Started clinical trials in the academic laboratory setting with 21 people with Parkinson’s and 15 healthy volunteers

Completed our 9 weeks home monitoring project with 5 people with Parkinson’s

Completed our first  external seed round of investors

Gained non-dilutive grants through the Innovation Technology Flemish Brabant Smart Hub and Technology located in the  Walloon Region of Belgium

Selected for Chicago Innovation Mentors at MATTER Health, Chicago

2017

Development of Minimal Viable Product for marker-less motion capturing

Consortium with academic, clinical and technology partners formed

2016

Incorporation of NeuroPath in Belgium

First economic mission to Texas

Commonly Asked Questions

Our methodical approach is focused on revealing the essence of each design challenge to allow us.

There are many variations of lorem spassages of Lorem Ipsum available internet tend to repeat predefined. There are many variations of lorem spassages.

There are many variations of lorem spassages of Lorem Ipsum available internet tend to repeat predefined. There are many variations of lorem spassages.

There are many variations of lorem spassages of Lorem Ipsum available internet tend to repeat predefined. There are many variations of lorem spassages.

European Headquarters

Belgium:
NeuroPath
La Lanterne, Rue Jean Burgers 2, 7850 Enghien
Technologielaan 9, 3001 Heverlee
Email: contact@neuropath.life

North American Operations

United States:
NeuroPath US, Inc.
222 W. Merchandise Mart Plaza, suite 1230
Chicago, IL 60654
Email: contact@neuropath.life